Bristol-Myers Squibb Company Total Assets

The latest total assets for BRM.DE is $88B as of June 2026. That compares with $14B in the prior-year period — up 544.2% year over year. Investors often review this figure alongside Bristol-Myers Squibb Company's historical trend and sector peers before judging valuation or financial health.

Over the past year, BRM.DE's total assets moved from $14B to $88B — a 544.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bristol-Myers Squibb Company's operating scale or balance-sheet position.

A total assets figure of $88B for BRM.DE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BRM.DE's total assets ($88B), review year-over-year change from $14B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Bristol-Myers Squibb Company's total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.